ADMA Biologics's total assets for Q4 2024 were $488.68M, an increase of 25.10% from the previous quarter. ADMA total liabilities were $139.66M for the fiscal quarter, a -12.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.